Armelle M. de Laforcade
Associate Professor
Emergency & Critical Care
Department of Clinical Sciences
Phone: 508-839-5395 x84415
Fax: 508-839-7922
Email: armelle.delaforcade@tufts.edu

Education

DVM - Tufts University - 1997
BS - Cornell University - 1993

Board Certification

American College of Veterinary Emergency & Critical Care (ACVECC)

House Officer Training

  • Rotating Small Animal Internship - The Animal Medical Center - New York, NY
  • Emergency & Critical Care Residency - Tufts Cummings School of Veterinary Medicine

Clinical Interests

  • Coagulation disorders; hypercoagulability; selection and monitoring of anticoagulation protocols

Teaching Interests

  • Coagulation, hypercoagulability, fluid therapy, sepsis, trauma

Main Teaching Responsibilities

  • Veterinary Economics & Practice Management (course director)
  • 2nd Year Clinical Rotations (course director)
  • Problem-Based Learning (PBL)
  • Small Animal Medicine (assessment and monitoring, sepsis)
  • Clinicl Pathology (hemostasis, anticoagulants, coagulation cases)
  • Toxicology (neurotoxins)

General Research Interest

  • Coagulation changes in critical illness and in severe trauma; development of protocols for anticoagulant use in the veterinary setting; monitoring anticoagulation therapy; diagnosis and management of severe sepsis and septic shock; alterations in microvascular perfusion in trauma and in critical illness.
Back to the Top

Selected Research Projects

  1. Evaluation of thromboelastography as a sensitive marker of coagulation abnormalities in sepsis
  2. Evaluation of thromboelastography in dogs following severe trauma
  3. Evaluating abdominal fluid cytology, biochemistry, and culture in dogs post-operatively following source control for abdominal sepsis

Major Specialized Equipment Available

  • Thromboelastograph
  • ACL Elite hemostasis analyzer
  • Multiplate aggregometer
  • Microscan video microscope

Selected Publications
  1. O'Marra SK, Shaw SP, de Laforcade AM. Investigating hypercoagulability in immune-mediated thrombocytopenia: a pilot study. In press, J Vet Emerg Crit Care.
  2. O'Marra SK, de Laforcade AM, Shaw SP. Treatment and predictors of out-come in dogs with immune mediated thrombocytopenia. J Am Vet Med Assoc. 2011; 238(3):346-352.
  3. Fenty RK, de Laforcade AM, Shaw SP, O'Toole TE. Identification of hyper-coagulability in dogs with primary immune-mediated hemolytic anemia by means of thromboelastography. J Am Vet Med Assoc. 2011; 238(4):463-467.
  4. Kenney EM, Rozanski EA, Rush JE, de Laforcade-Buress AM, Berg JR, Silverstein DC, Montealegre CD, Jutkowitz LA, Adamantos S, Ovbey DH, Boysen SR, Shaw SP. Association between outcome and organ system dysfunction in dogs with sepsis: 114 cases (2003-2007). J Am Vet Med Assoc. 2010; 236:83-87.
  5. Streeter EM, Rozanski EA, de Laforcade-Buress AM, Freeman LM, Rush JE. Evaluation of vehicular trauma: 239 cases (January-December 2001). J Am Vet Med Assoc. 2009; 235(4):405-8.
  6. Whelan MF, O'Toole TE, Chan DL, Rozanski EA, de Laforcade AM, Crawford SL, Cotter SM. Use of human immunoglobulin in addition to glucocorticoids for the initial treatment of dogs with immune-mediated hemolytic anemia. J Vet Emerg Crit Care. 2009; 19(2):158-164.
  7. Trow AV, Rozanski EA, de Laforcade AM, Chan DL. Evaluation of use of human albumin in critically ill dogs: 73 cases (2003-2006). J Am Vet Med Assoc. 2008; 233:607-612.
  8. Roux FA, Deschamps JY, Blais MC, Welsh DM, de Laforcade-Buress AM, Rozanski EA. Multiple red cell transfusions in 27 cats (2003-2006): Indications, complications, and outcomes. J Feline Med Surg. 2008; 10:213-218.
Back to the Top